Cardioversion of atrial fibrillation and atrial flutter revisited: current evidence and practical guidance for a common procedure

Axel Brandes*, Harry J G M Crijns, Michiel Rienstra, Paulus Kirchhof, Erik L Grove, Kenneth Bruun Pedersen, Isabelle C Van Gelder

*Corresponding author for this work

Research output: Contribution to journalJournal articleResearchpeer-review

20 Downloads (Pure)

Abstract

Cardioversion is widely used in patients with atrial fibrillation (AF) and atrial flutter when a rhythm control strategy is pursued. We sought to summarize the current evidence on this important area of clinical management of patients with AF including electrical and pharmacological cardioversion, peri-procedural anticoagulation and thromboembolic complications, success rate, and risk factors for recurrence to give practical guidance.

Original languageEnglish
JournalEuropace
Volume22
Issue number8
Pages (from-to)1149-1161
ISSN1099-5129
DOIs
Publication statusPublished - 1. Aug 2020

Bibliographical note

© The Author(s) 2020. Published by Oxford University Press on behalf of the European Society of Cardiology.

Keywords

  • Anticoagulation
  • Atrial fibrillation
  • Atrial flutter
  • Electrical cardioversion
  • Pharmacological cardioversion
  • Thromboembolism

Fingerprint Dive into the research topics of 'Cardioversion of atrial fibrillation and atrial flutter revisited: current evidence and practical guidance for a common procedure'. Together they form a unique fingerprint.

Cite this